Additional file 4: Fig. S4. The top 4 significantly decreased microbial pathways in CADASIL patients compared to healthy controls, and the abundance of their contributed species within case and control groups, respectively. The average relative abundance was shown on the right of the stacked bar plots. Species and “unclassified” stratifications are linearly (proportionally) scaled within the total bar height. Case, N=24; Control, N=28
Additional file 3: Fig. S3. Species correlation and co-occurrence network between patients and healt...
Additional file 1: Fig. S1. Flow chart and enrolled participants in the current study
Additional file 22: Table S12. The content of serum glutamic acid and gamma-aminobutyric acid and th...
Additional file 7: Fig. S7. Stacked bar plot shows the relative abundance of contributing species to...
Additional file 16: Table S6. The significantly different functional pathways in relative abundance ...
Additional file 15: Table S5. The significantly different species in relative abundance between CADA...
Additional file 5: Fig. S5. Relative abundance of the top 5 contributing species in the control grou...
Additional file 21: Table S11. The statistical result of serum neurotransmitters of CADASIL patients...
Additional file 24: Table S14. Differentiated abundant VFs in CADASIL patients compared to controls
Additional file 8: Fig. S8. The comparison of VFs in two groups of metagenomic samples. (A) The CPM ...
Additional file 9: Fig. S9. The significantly decreased virulence factors (VFs) in relative abundanc...
Additional file 23: Table S13. The serum cytokines in 12 CADASIL patients (Case) and 10 healthy fami...
Additional file 25: Table S15. Significantly decreased VFs in CADASIL patients compared to controls
Additional file 2: Fig. S2. The relative abundance of significantly different genera in fecal metage...
Additional file 17: Table S7. The significantly different content of fecal metabolites between CADAS...
Additional file 3: Fig. S3. Species correlation and co-occurrence network between patients and healt...
Additional file 1: Fig. S1. Flow chart and enrolled participants in the current study
Additional file 22: Table S12. The content of serum glutamic acid and gamma-aminobutyric acid and th...
Additional file 7: Fig. S7. Stacked bar plot shows the relative abundance of contributing species to...
Additional file 16: Table S6. The significantly different functional pathways in relative abundance ...
Additional file 15: Table S5. The significantly different species in relative abundance between CADA...
Additional file 5: Fig. S5. Relative abundance of the top 5 contributing species in the control grou...
Additional file 21: Table S11. The statistical result of serum neurotransmitters of CADASIL patients...
Additional file 24: Table S14. Differentiated abundant VFs in CADASIL patients compared to controls
Additional file 8: Fig. S8. The comparison of VFs in two groups of metagenomic samples. (A) The CPM ...
Additional file 9: Fig. S9. The significantly decreased virulence factors (VFs) in relative abundanc...
Additional file 23: Table S13. The serum cytokines in 12 CADASIL patients (Case) and 10 healthy fami...
Additional file 25: Table S15. Significantly decreased VFs in CADASIL patients compared to controls
Additional file 2: Fig. S2. The relative abundance of significantly different genera in fecal metage...
Additional file 17: Table S7. The significantly different content of fecal metabolites between CADAS...
Additional file 3: Fig. S3. Species correlation and co-occurrence network between patients and healt...
Additional file 1: Fig. S1. Flow chart and enrolled participants in the current study
Additional file 22: Table S12. The content of serum glutamic acid and gamma-aminobutyric acid and th...